A Food Effect Study in Healthy Volunteers With Belzutifan (PT2977, MK-6482) Tablets
Clinical trial NCT03445169 · COMPLETED
Trial details
- NCT number
- NCT03445169
- Sponsor
- Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-23
- Primary completion
- 2018-05-26
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.